Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sky High VC is a US-based early-stage venture capital fund founded on August 27, 2021. The firm is dedicated to investing in high-impact 'changemaker' startups, particularly within the biotech and health tech sectors. With a fund size of $50 million, Sky High VC aims to deploy capital across approximately 20 portfolio companies over a 10-year period. The organization is backed by a team with extensive experience in Latin American finance and biotech, positioning it uniquely to support startups in this region.
Since its inception, Sky High VC has focused on innovative and sustainable solutions, particularly in precision medicine, genomics, and machine learning. The firm operates globally but emphasizes opportunities in Latin America, where it seeks to make a significant impact. The team’s deep roots in the region enhance their ability to identify and support promising entrepreneurs.
Sky High VC invests in early-stage startups across several sectors, including biotech, healthcare, artificial intelligence, fintech, and climate technology. The firm specifically targets companies that are innovative and sustainable, with a strong emphasis on precision medicine and genomics. Investment stages range from pre-seed to Series A, allowing the firm to engage with startups at various points in their development.
The fund seeks to support entrepreneurs who are positioned to make significant impacts in their respective fields. Sky High VC looks for founders who demonstrate a clear vision and the capability to execute their ideas effectively. The firm prefers to structure deals that allow for strategic support and collaboration, leveraging its network of experienced advisors and partners.
Sky High VC's portfolio includes notable companies that exemplify its investment thesis:
These companies reflect Sky High VC's commitment to supporting innovative solutions in healthcare and biotechnology, particularly in regions that require enhanced access to advanced medical technologies.
Gustavo Rapisardi — General Partner. Gustavo has over 35 years of financial experience, having held previous roles at Grupo Petersen and Itaú Unibanco. He holds degrees in Law and Economics from the University of Buenos Aires.
Andrei Afanasiev — Venture Partner. Andrei brings over 15 years of experience in biotech and pharma, having founded three startups, including a genetic testing company that achieved an M&A exit. He has authored eight papers and holds two patents, with a strong background in R&D within the pharmaceutical sector.
Consuelo Valverde — Founder & Managing Partner, SV LATAM Capital. Consuelo is recognized as the first Mexican woman to establish an early-stage VC in Mexico and Silicon Valley and has been named one of the 100 Most Influential Latinas three times.
Vartan Indjeian — CFO, SV LATAM Capital. Vartan has over 10 years of experience in private equity and venture capital audit at KPMG and holds a Master's degree in Finance from London Business School.
Juan Carlos Felix — Formerly with Carlyle Group Brazil/South America, Juan Carlos has raised over $1.5 billion and led approximately $3 billion in deals. He holds an MBA from Harvard University.
Pablo Solá — Private Equity Leader at EY Latin America, Pablo has 16 years of experience advising across the US, Latin America, Europe, and the UK.
Michael Spencer — Partner at MDS Advisory, Michael is a dual-qualified lawyer and quantity surveyor with expertise in construction and technology contracts.
To pitch Sky High VC, founders should visit skyhighfund.com and submit their proposals through the designated channels. The firm prefers detailed decks that include information on the startup's vision, market analysis, competitive landscape, and team qualifications. Response times may vary, but founders can expect to hear back within a few weeks.
Sky High VC has been actively seeking to support early-stage startups since its founding in 2021. The firm has published information about its investment focus and notable portfolio companies, indicating a commitment to engaging with innovative entrepreneurs. However, no recent blog posts or updates have been detected.
What are Sky High VC's investment criteria?
Sky High VC focuses on early-stage startups in sectors such as biotech, healthcare, AI, fintech, and climate technology. The firm looks for innovative and sustainable solutions, particularly in precision medicine and genomics.
How can I pitch to Sky High VC?
Founders can submit their pitches through the official website at skyhighfund.com. The firm encourages detailed presentations that outline the startup's vision, market potential, and team capabilities.
What makes Sky High VC different from other investors?
Sky High VC emphasizes a strong connection to Latin America and has a team with deep expertise in finance and biotech. This unique positioning allows the firm to provide tailored support to its portfolio companies.
What is the typical check size for investments?
While specific check sizes are not disclosed, Sky High VC aims to deploy its $50 million fund across approximately 20 companies, indicating a focus on meaningful investments that can drive significant impact.
What is the geographic focus of Sky High VC?
The firm has a global investment strategy but places a strong emphasis on opportunities in Latin America, leveraging its team's regional expertise to identify promising startups.
What kind of support does Sky High VC provide to its portfolio companies?
Sky High VC offers strategic support through a network of experienced advisors and partners, helping startups navigate challenges and scale effectively in their respective markets.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.